|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/573 | |
| A61P 27/02 | |||
| A61K 9/10 | |||
| A61K 47/30 | |||
| A61K 9/00 |
| (11) | Number of the document | 2216026 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10154221.5 |
| Date of filing the European patent application | 2005-07-11 | |
| (97) | Date of publication of the European application | 2010-08-11 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 587092 | 2004-07-12 | US |
| (72) |
Whitcup, Scott M., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | Ophthalmic compositions and uses for treating ophthalmic conditions |
| Ophthalmic compositions and uses for treating ophthalmic conditions |